Jubilee Mission Medical College and Research Institute, Thrissur, India Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2017
NCT03109119
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Jubilee Mission Medical College and Research Institute

Active Ingredients

Drugs in Phase 4 Trials (2)

propofol (diprivan) (1 trial)

sevoflurane (ultane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Genomic Instability (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2